On the recordApril 17, 2012
I appreciate the fact that you are working through this problem with getting a new over-the-counter preparation available, but as you pointed out, you have difficulty with bioequivalency.
Source
congress.govEditor's note · Context
Burgess acknowledges efforts to resolve inhaler availability issues but notes challenges with new formulations.
Share & report
More from Michael Burgess
Dec 4, 2024
Mr. Speaker, I reserve the balance of my time. Mr. McGOVERN. Mr. Speaker, I yield myself such time as I may consume. One of the bills that is being brought before us, H.R. 7198, is a Republican partisan bill, but it violates their own…
Jul 24, 2024
Mr. Speaker, honestly, I keep hearing the term ``MAGA'' used by the other side. I am referred to as MAGA. You keep saying that word. I don't think you know what it means. It is an acronym that stands for Make America Great Again. I don't…
Sep 24, 2024
Madam Speaker, I yield myself 2 minutes. The rules brought forth today, two are closed, but in both instances, neither received an amendment in which to make in order. If there are no amendments, by definition, then it is a closed rule. I…
Dec 4, 2024
Mr. Speaker, I reserve the balance of my time. Mr. McGOVERN. Mr. Speaker, may I inquire whether the gentleman wants to answer the CBO question or whether he wants me to close?
Other voices in this conversation
